MedTrace Logo

Effect of Tadalafil on Endometrial Thickness and Frozen Embryo Transfer Outcomes

NCT07499804 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-03-30

No results posted yet for this study

Summary

investigate the effect of different vasodilators as Tadalafil in women with unexplained infertility using IVF

Conditions

  • IVF
  • Infertility, Female

Interventions

DRUG

Tadalafil 5mg

phosphodiesterase type 5 (PDE-5) inhibitor

DRUG

estradiol valerate 2 mg

estradiol valerate 2 mg. in form of (Cycloprogynova® Bayer Shering Pharma) white pills starting dose is one pill T.I.D may be increased to two pills T.I.D according to endometrial thickness in day 9 measured by vaginal ultrasound.

Sponsors & Collaborators

  • Beni-Suef University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
43 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2026-04-30
Completion
2026-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07499804 on ClinicalTrials.gov